Neuronetics Inc. (NASDAQ: STIM)
$1.5100
+0.0200 ( +1.34% ) 120.8K
Neuronetics Inc a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders. Its first commercial product, the NeuroStar Advanced Therapy System, is a non-invasive and non-systemic office-based treatment that uses transcranial magnetic stimulations, or TMS, to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company designed the NeuroStar Advanced Therapy as a non-invasive therapeutic alternative to treat patients who suffer from MDD and to address many of the key limitations of existing treatment options.
Market Data
Open
$1.5100
Previous close
$1.4900
Volume
120.8K
Market cap
$84.04M
Day range
$1.4450 - $1.5450
52 week range
$0.5200 - $5.0699
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
3 | Insider transactions | 2 | Dec 19, 2024 |
3 | Insider transactions | 2 | Dec 19, 2024 |
3 | Insider transactions | 1 | Dec 19, 2024 |
4 | Insider transactions | 1 | Dec 12, 2024 |
4 | Insider transactions | 1 | Dec 12, 2024 |
4 | Insider transactions | 1 | Dec 12, 2024 |
8-k | 8K-related | 16 | Dec 10, 2024 |
8-k/a | 8K-related | 15 | Nov 13, 2024 |
8-k | 8K-related | 13 | Nov 13, 2024 |
10-q | Quarterly Reports | 87 | Nov 12, 2024 |